Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss.
about
Preservation and promotion of bone formation in the mandible as a response to a novel calcium-phosphate based biomaterial in mineral deficiency induced low bone mass male versus female ratsOsteocytic signalling pathways as therapeutic targets for bone fragility.Bone-seeking agents for the treatment of bone disorders.Bisphosphonate conjugation for bone specific drug targeting.
P2860
Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Novel EP4 receptor agonist-bis ...... l of postmenopausal bone loss.
@en
Novel EP4 receptor agonist-bisphosphonate conjugate drug
@nl
type
label
Novel EP4 receptor agonist-bis ...... l of postmenopausal bone loss.
@en
Novel EP4 receptor agonist-bisphosphonate conjugate drug
@nl
prefLabel
Novel EP4 receptor agonist-bis ...... l of postmenopausal bone loss.
@en
Novel EP4 receptor agonist-bisphosphonate conjugate drug
@nl
P2093
P2860
P356
P1476
Novel EP4 receptor agonist-bis ...... l of postmenopausal bone loss.
@en
P2093
Careesa C Liu
Marc D Grynpas
Nag S Kumar
Robert N Young
Steve Arns
P2860
P304
P356
10.1002/JBMR.2382
P577
2015-04-01T00:00:00Z